A Study in Healthy Adults to Evaluate the Safety and Immunogenicity of Different Doses of JNJ-63871860
Clinical trial NCT02546960 · COMPLETED
Trial details
- NCT number
- NCT02546960
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-12
- Primary completion
- 2016-09-12
- Enrollment
- 848
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.